US MFN Drug Pricing & European Market Access: Strategic Briefing for 2027
Strategies for managing uncertainty in the global pharmaceutical business
- First-hand insights from a former HHS insider
- Strategic guidance for global pharma decisions
- Officially certified according to ISO 9001 and ISO 21001
Online-Seminar
From
690,00 €
plus VAT
Services & Process
Veranstaltung - 690,-€ zzgl. MwSt.
The fee includes high-quality course material for download, a certificate of participation, access to our Learning Space and technical support, including a test meeting.
Booking details
Online-Seminar
From
690,00 €
plus VAT
Services & Process
Veranstaltung - 690,-€ zzgl. MwSt.
The fee includes high-quality course material for download, a certificate of participation, access to our Learning Space and technical support, including a test meeting.
The US Most Favored Nation policy is already reshaping pharmaceutical pricing in Europe. Kristie Champlin Gurley, formerly with the US Department of Health and Human Services where she advised directly on the CMS drug pricing portfolio, brings first-hand regulatory insight into how GUARD and GLOBE were designed. Leave with concrete strategic orientation for 2027.
Your speakers
Kristie Champlin Gurley
Covington & Burling LLP, Washington, DC
Kristie Gurley advises life sciences clients on complex pricing, reimbursement, and market access issues for drugs and biological products. She previously served…
Your speaker
Kristie Champlin Gurley
Covington & Burling LLP, Washington, DC
Kristie Gurley advises life sciences clients on complex pricing, reimbursement, and market access issues for drugs and biological products. She previously served in the Office of the General Counsel at the U.S. Department of Health and Human Services, where she was a lead attorney for implementation of the Inflation Reduction Act’s Medicare Drug Price Negotiation and Inflation Rebate Programs, as well as Medicaid Drug Rebate Program rulemaking and CMS innovation initiatives for cell and gene therapies. In private practice, she provides strategic, policy, and regulatory advice on federal health care program coverage and reimbursement, Medicaid price reporting, agency engagement, payer and value-based contracting, and broader commercial, compliance, litigation, and policy advocacy matters.
Dr. Dr. Adem Koyuncu
Law firm Covington & Burling LLP,
Brussels & Frankfurt
Lawyer and Medical Doctor,
Partner in the Brussels and Frankfurt offices
Your speaker
Dr. Dr. Adem Koyuncu
Law firm Covington & Burling LLP,
Brussels & Frankfurt
Lawyer and Medical Doctor,
Partner in the Brussels and Frankfurt offices
Dr. Sebastian Werner
vfa - Verband Forschender Arzneimittelhersteller e. V., Berlin
Dr Sebastian Werner is a Market Access and HTA Specialist at the vfa (German Association of Research-Based Pharmaceutical Companies)
and…
Your speaker
Dr. Sebastian Werner
vfa - Verband Forschender Arzneimittelhersteller e. V., Berlin
Dr Sebastian Werner is a Market Access and HTA Specialist at the vfa (German Association of Research-Based Pharmaceutical Companies)
and serves there as an expert on benefit assessment and market access issues, with a focus on EU HTA and EU market regulations.
Previously, he worked, among other roles, in the drug assessment department at IQWiG and conducted research at the Max Planck Institute for Biological Cybernetics and the Hertie Institute for Clinical Brain Research. He is a psychologist and a neuroscientist specialising in neuro- and behavioural sciences.
What to Expect
- Political background and evolution of MFN thinking
- GUARD and GLOBE in detail: objectives, scope, design features, similarities and differences, proposed timelines and implementation pathways
- MFN and European pricing fundamentals: interaction with national pricing and reimbursement systems, consequences for confidential discounts and managed entry agreements
- Global market launch sequence: how is MFN changing it?
Who Should Attend
This seminar is aimed at professionals in the pharmaceutical and biotech industry responsible for pricing, market access and reimbursement.
Participants should be familiar with the fundamentals of International Reference Pricing (IRP). Prior knowledge of GUARD and GLOBE is not required.
Objective of the Event
This online seminar provides pricing, market access and regulatory professionals with a structured and expert-guided overview of the current MFN policy landscape and its direct consequences for European pharmaceutical pricing. Participants gain a clear understanding of the proposed GUARD and GLOBE models, their interaction with International Reference Pricing, and the strategic implications for global launch sequencing ahead of 2027.
Your Benefit
- You understand the full MFN toolkit and how the proposed GUARD and GLOBE models are designed to interact with existing pricing and reimbursement frameworks.
- You assess the potential impact of MFN on European net prices, confidential discounts and managed entry agreements before the relevant deadlines.
- You can evaluate how MFN changes the logic of global market launch sequencing and what strategic adjustments may be required.
- You leave with orientation for your pricing and market access planning for 2027.
Programme
02:00 p.m. - 05:00 p.m.
14:00
14:15
Kristie Champlin Gurley
- Political background: evolution of MFN thinking in key markets, from national initiatives to coordinated international approaches
- MFN toolkit overview: types of MFN clauses and mechanisms, interaction with price agreements, discounts and data transparency
- Deep dive: GUARD and GLOBE, objectives, scope, design features, similarities and differences, expected timelines and implementation pathways
- Further geopolitical deals and initiatives
15:15
15:30
Dr. Dr. Adem Koyuncu
- MFN and European pricing fundamentals: interaction with national pricing and reimbursement systems, consequences for confidential discounts and managed entry agreements
- Impact on International Reference Pricing (IRP): how MFN provisions may amplify IRP effects, risk of price spillover and unintended reference chains
16:15
Dr. Sebastian Werner
17:00
Welcome and introduction
14:15
The global MFN landscape towards 2027
The global MFN landscape towards 2027
Kristie Champlin Gurley
- Political background: evolution of MFN thinking in key markets, from national initiatives to coordinated international approaches
- MFN toolkit overview: types of MFN clauses and mechanisms, interaction with price agreements, discounts and data transparency
- Deep dive: GUARD and GLOBE, objectives, scope, design features, similarities and differences, expected timelines and implementation pathways
- Further geopolitical deals and initiatives
Break
15:30
What MFN means for European pricing and International Reference Pricing
What MFN means for European pricing and International Reference Pricing
Dr. Dr. Adem Koyuncu
- MFN and European pricing fundamentals: interaction with national pricing and reimbursement systems, consequences for confidential discounts and managed entry agreements
- Impact on International Reference Pricing (IRP): how MFN provisions may amplify IRP effects, risk of price spillover and unintended reference chains
Global market launch sequence - how is MFN changing it? What needs to change in the EU?
End
Downloads
Request the documents using our form.
Further Informations
Technical requirements
You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.
We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.
Access to and procedure for online events
Once you have registered for an event, we will send you the access information for your customer portal. Click here to log in to the customer portal using your email address and password. Please ensure you can access the customer portal before the day of the event.
All important or additional information and personal documents are available in your personalised customer portal. This is also where you start your online courses. If you do not have access to the customer portal yet, you can easily register here.
On the day of the event, you kick off your online training in the customer portal by clicking ‘Participate’ directly in the respective event. You will then be redirected to the Learning Space.
Learn more about our online events here.
Our Recommendations
Further Information
e-Learning - Click and learn
We provide flexible education and training with high-quality e-Learning programmes for several topics.
List of abbreviations pharma & healthcare
Many abbreviations are used in pharma & healthcare. Download the list of the most important ones.
Our rating in 2025
More than 3,700 customers have rated our training courses. Thank you for awarding us 4.4 stars out of 5.
Your Contact Person
We are happy to advise you personally and individually.
Leila Dörfler
Team Leader
+49 6221 500-695
l.doerfler@forum-institut.de